The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study

Comparative effectiveness of a time-varying treatment with competing risks

John B. Holcomb, Deborah J. Del Junco, Erin E. Fox, Charles E. Wade, Mitchell J. Cohen, Martin A. Schreiber, Louis H. Alarcon, Yu Bai, Karen J. Brasel, Eileen M. Bulger, Bryan A. Cotton, Nena Matijevic, Peter Muskat, John G. Myers, Herb A. Phelan, Christopher E. White, Jiajie Zhang, Mohammad H. Rahbar

Research output: Contribution to journalArticle

384 Citations (Scopus)

Abstract

Objective: To relate in-hospital mortality to early transfusion of plasma and/or platelets and to time-varying plasma: red blood cell (RBC) and platelet:RBC ratios. Design: Prospective cohort study documenting the timing of transfusions during active resuscitation and patient outcomes. Data were analyzed using timedependent proportional hazards models. Setting: Ten US level I trauma centers. Patients: Adult trauma patients surviving for 30 minutes after admission who received a transfusion of at least 1 unit of RBCs within 6 hours of admission (n=1245, the original study group) and at least 3 total units (of RBCs, plasma, or platelets) within 24 hours (n=905, the analysis group). Main Outcome Measure: In-hospital mortality. Results: Plasma:RBC and platelet:RBC ratios were not constant during the first 24 hours (P<.001 for both). In a multivariable time-dependent Cox model, increased ratios of plasma:RBCs (adjusted hazard ratio= 0.31; 95% CI, 0.16-0.58) and platelets:RBCs (adjusted hazard ratio=0.55; 95% CI, 0.31-0.98) were independently associated with decreased 6-hour mortality, when hemorrhagic death predominated. In the first 6 hours, patients with ratios less than 1:2 were 3 to 4 times more likely to die than patients with ratios of 1:1 or higher. After 24 hours, plasma and platelet ratios were unassociated with mortality, when competing risks from nonhemorrhagic causes prevailed. Conclusions: Higher plasma and platelet ratios early in resuscitation were associated with decreased mortality in patients who received transfusions of at least 3 units of blood products during the first 24 hours after admission. Among survivors at 24 hours, the subsequent risk of death by day 30 was not associated with plasma or platelet ratios.

Original languageEnglish (US)
Pages (from-to)127-136
Number of pages10
JournalJAMA Surgery
Volume148
Issue number2
DOIs
StatePublished - Feb 2013

Fingerprint

Blood Platelets
Wounds and Injuries
Erythrocytes
Therapeutics
Hospital Mortality
Proportional Hazards Models
Resuscitation
Mortality
Trauma Centers
Survivors
Cohort Studies
Outcome Assessment (Health Care)
Prospective Studies

ASJC Scopus subject areas

  • Surgery

Cite this

The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study : Comparative effectiveness of a time-varying treatment with competing risks. / Holcomb, John B.; Del Junco, Deborah J.; Fox, Erin E.; Wade, Charles E.; Cohen, Mitchell J.; Schreiber, Martin A.; Alarcon, Louis H.; Bai, Yu; Brasel, Karen J.; Bulger, Eileen M.; Cotton, Bryan A.; Matijevic, Nena; Muskat, Peter; Myers, John G.; Phelan, Herb A.; White, Christopher E.; Zhang, Jiajie; Rahbar, Mohammad H.

In: JAMA Surgery, Vol. 148, No. 2, 02.2013, p. 127-136.

Research output: Contribution to journalArticle

Holcomb, JB, Del Junco, DJ, Fox, EE, Wade, CE, Cohen, MJ, Schreiber, MA, Alarcon, LH, Bai, Y, Brasel, KJ, Bulger, EM, Cotton, BA, Matijevic, N, Muskat, P, Myers, JG, Phelan, HA, White, CE, Zhang, J & Rahbar, MH 2013, 'The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: Comparative effectiveness of a time-varying treatment with competing risks', JAMA Surgery, vol. 148, no. 2, pp. 127-136. https://doi.org/10.1001/2013.jamasurg.387
Holcomb, John B. ; Del Junco, Deborah J. ; Fox, Erin E. ; Wade, Charles E. ; Cohen, Mitchell J. ; Schreiber, Martin A. ; Alarcon, Louis H. ; Bai, Yu ; Brasel, Karen J. ; Bulger, Eileen M. ; Cotton, Bryan A. ; Matijevic, Nena ; Muskat, Peter ; Myers, John G. ; Phelan, Herb A. ; White, Christopher E. ; Zhang, Jiajie ; Rahbar, Mohammad H. / The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study : Comparative effectiveness of a time-varying treatment with competing risks. In: JAMA Surgery. 2013 ; Vol. 148, No. 2. pp. 127-136.
@article{dd91382767b24ada898d556218bf5f4a,
title = "The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: Comparative effectiveness of a time-varying treatment with competing risks",
abstract = "Objective: To relate in-hospital mortality to early transfusion of plasma and/or platelets and to time-varying plasma: red blood cell (RBC) and platelet:RBC ratios. Design: Prospective cohort study documenting the timing of transfusions during active resuscitation and patient outcomes. Data were analyzed using timedependent proportional hazards models. Setting: Ten US level I trauma centers. Patients: Adult trauma patients surviving for 30 minutes after admission who received a transfusion of at least 1 unit of RBCs within 6 hours of admission (n=1245, the original study group) and at least 3 total units (of RBCs, plasma, or platelets) within 24 hours (n=905, the analysis group). Main Outcome Measure: In-hospital mortality. Results: Plasma:RBC and platelet:RBC ratios were not constant during the first 24 hours (P<.001 for both). In a multivariable time-dependent Cox model, increased ratios of plasma:RBCs (adjusted hazard ratio= 0.31; 95{\%} CI, 0.16-0.58) and platelets:RBCs (adjusted hazard ratio=0.55; 95{\%} CI, 0.31-0.98) were independently associated with decreased 6-hour mortality, when hemorrhagic death predominated. In the first 6 hours, patients with ratios less than 1:2 were 3 to 4 times more likely to die than patients with ratios of 1:1 or higher. After 24 hours, plasma and platelet ratios were unassociated with mortality, when competing risks from nonhemorrhagic causes prevailed. Conclusions: Higher plasma and platelet ratios early in resuscitation were associated with decreased mortality in patients who received transfusions of at least 3 units of blood products during the first 24 hours after admission. Among survivors at 24 hours, the subsequent risk of death by day 30 was not associated with plasma or platelet ratios.",
author = "Holcomb, {John B.} and {Del Junco}, {Deborah J.} and Fox, {Erin E.} and Wade, {Charles E.} and Cohen, {Mitchell J.} and Schreiber, {Martin A.} and Alarcon, {Louis H.} and Yu Bai and Brasel, {Karen J.} and Bulger, {Eileen M.} and Cotton, {Bryan A.} and Nena Matijevic and Peter Muskat and Myers, {John G.} and Phelan, {Herb A.} and White, {Christopher E.} and Jiajie Zhang and Rahbar, {Mohammad H.}",
year = "2013",
month = "2",
doi = "10.1001/2013.jamasurg.387",
language = "English (US)",
volume = "148",
pages = "127--136",
journal = "JAMA Surgery",
issn = "2168-6254",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study

T2 - Comparative effectiveness of a time-varying treatment with competing risks

AU - Holcomb, John B.

AU - Del Junco, Deborah J.

AU - Fox, Erin E.

AU - Wade, Charles E.

AU - Cohen, Mitchell J.

AU - Schreiber, Martin A.

AU - Alarcon, Louis H.

AU - Bai, Yu

AU - Brasel, Karen J.

AU - Bulger, Eileen M.

AU - Cotton, Bryan A.

AU - Matijevic, Nena

AU - Muskat, Peter

AU - Myers, John G.

AU - Phelan, Herb A.

AU - White, Christopher E.

AU - Zhang, Jiajie

AU - Rahbar, Mohammad H.

PY - 2013/2

Y1 - 2013/2

N2 - Objective: To relate in-hospital mortality to early transfusion of plasma and/or platelets and to time-varying plasma: red blood cell (RBC) and platelet:RBC ratios. Design: Prospective cohort study documenting the timing of transfusions during active resuscitation and patient outcomes. Data were analyzed using timedependent proportional hazards models. Setting: Ten US level I trauma centers. Patients: Adult trauma patients surviving for 30 minutes after admission who received a transfusion of at least 1 unit of RBCs within 6 hours of admission (n=1245, the original study group) and at least 3 total units (of RBCs, plasma, or platelets) within 24 hours (n=905, the analysis group). Main Outcome Measure: In-hospital mortality. Results: Plasma:RBC and platelet:RBC ratios were not constant during the first 24 hours (P<.001 for both). In a multivariable time-dependent Cox model, increased ratios of plasma:RBCs (adjusted hazard ratio= 0.31; 95% CI, 0.16-0.58) and platelets:RBCs (adjusted hazard ratio=0.55; 95% CI, 0.31-0.98) were independently associated with decreased 6-hour mortality, when hemorrhagic death predominated. In the first 6 hours, patients with ratios less than 1:2 were 3 to 4 times more likely to die than patients with ratios of 1:1 or higher. After 24 hours, plasma and platelet ratios were unassociated with mortality, when competing risks from nonhemorrhagic causes prevailed. Conclusions: Higher plasma and platelet ratios early in resuscitation were associated with decreased mortality in patients who received transfusions of at least 3 units of blood products during the first 24 hours after admission. Among survivors at 24 hours, the subsequent risk of death by day 30 was not associated with plasma or platelet ratios.

AB - Objective: To relate in-hospital mortality to early transfusion of plasma and/or platelets and to time-varying plasma: red blood cell (RBC) and platelet:RBC ratios. Design: Prospective cohort study documenting the timing of transfusions during active resuscitation and patient outcomes. Data were analyzed using timedependent proportional hazards models. Setting: Ten US level I trauma centers. Patients: Adult trauma patients surviving for 30 minutes after admission who received a transfusion of at least 1 unit of RBCs within 6 hours of admission (n=1245, the original study group) and at least 3 total units (of RBCs, plasma, or platelets) within 24 hours (n=905, the analysis group). Main Outcome Measure: In-hospital mortality. Results: Plasma:RBC and platelet:RBC ratios were not constant during the first 24 hours (P<.001 for both). In a multivariable time-dependent Cox model, increased ratios of plasma:RBCs (adjusted hazard ratio= 0.31; 95% CI, 0.16-0.58) and platelets:RBCs (adjusted hazard ratio=0.55; 95% CI, 0.31-0.98) were independently associated with decreased 6-hour mortality, when hemorrhagic death predominated. In the first 6 hours, patients with ratios less than 1:2 were 3 to 4 times more likely to die than patients with ratios of 1:1 or higher. After 24 hours, plasma and platelet ratios were unassociated with mortality, when competing risks from nonhemorrhagic causes prevailed. Conclusions: Higher plasma and platelet ratios early in resuscitation were associated with decreased mortality in patients who received transfusions of at least 3 units of blood products during the first 24 hours after admission. Among survivors at 24 hours, the subsequent risk of death by day 30 was not associated with plasma or platelet ratios.

UR - http://www.scopus.com/inward/record.url?scp=84874254007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874254007&partnerID=8YFLogxK

U2 - 10.1001/2013.jamasurg.387

DO - 10.1001/2013.jamasurg.387

M3 - Article

VL - 148

SP - 127

EP - 136

JO - JAMA Surgery

JF - JAMA Surgery

SN - 2168-6254

IS - 2

ER -